Cargando…
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
Autores principales: | Guo, Zhinian, Chen, Yunlong, Luo, Xiaoyu, He, Xiaolong, Zhang, Yong, Wang, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351637/ https://www.ncbi.nlm.nih.gov/pubmed/32653043 http://dx.doi.org/10.1186/s13054-020-03142-8 |
Ejemplares similares
-
Single-cell transcriptome analysis of uncultured human umbilical cord mesenchymal stem cells
por: Zhang, Shaoyang, et al.
Publicado: (2021) -
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
por: Shu, Lei, et al.
Publicado: (2020) -
Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia
por: Chu, Meiping, et al.
Publicado: (2022) -
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
por: Feng, Ying, et al.
Publicado: (2020) -
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia
por: Ciccocioppo, Rachele, et al.
Publicado: (2021)